Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Francoise Bernaudin, MD, Azadeh Djavidi, MD, Cécile Arnaud, MD, Annie Kamdem, MD, Isabelle Hau, MD, Corinne Pondarré, MD PhD, Jean-Paul Vernant, MD, Mathieu Kuentz, MD, Nathalie Dhedin, MD, Jean-Hugues Dalle, MD PhD, Eliane Gluckman, Gerard Socie, MD PhD

Blood (2019) 134 (Supplement_1): 2253.

https://doi.org/10.1182/blood-2019-125316

Published: 2019

Journal Articles

Alternative Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Europe

Blood (2018) 132 (Supplement 1): 4645.

https://doi.org/10.1182/blood-2018-99-111129

Published: 2018

Journal Articles

Risk Factors and Outcomes According to Age at Transplant with an HLA Identical Sibling for Sickle Cell Disease

Blood (2017) 130 (Supplement 1): 3317.

https://doi.org/10.1182/blood.V130.Suppl_1.3317.3317

Published: 2017

Journal Articles

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Blood (2017) 129 (11): 1548–1556.

https://doi.org/10.1182/blood-2016-10-745711

Published: 2017

Journal Articles

Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative

Nathalie Dhedin, MD, Josu de la Fuente, Francoise Bernaudin, MD, Mathieu Kuentz, MD, Leena Karnik, MD FRCPath, MBBS,, Tatsuki Koyama, PhD, Robert A. Brodsky, MD, Michael DeBaun, MD, Adetola A. Kassim, MD MS

Blood (2016) 128 (22): 1233.

https://doi.org/10.1182/blood.V128.22.1233.1233

Published: 2016

Journal Articles

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Francoise Bernaudin, MD, Dominique Bories, MD, PHD, Jean-Hugues Dalle, MD, PHD, Marie Robin, MD, PhD, Regis Peffault de Latour, Benedicte Neven, Yves Bertrand, MD, Corinne Pondarre, MD, PHD, Jean-Pierre Vannier, Karima Yakouben, Mathieu Kuentz, Catherine Cordonnier, Nathalie Dhedin, MD, Isabelle Thuret, Patrick Lutz, Eliane Gluckman, MD, Gérard Socié, MD, PhD

Blood (2013) 122 (21): 971.

https://doi.org/10.1182/blood.V122.21.971.971

Published: 2013

Journal Articles

Haplo-BMT: cure or back to sickle cell?

Françoise Bernaudin, Mathieu Kuentz

Blood (2012) 120 (22): 4276–4277.

https://doi.org/10.1182/blood-2012-09-455832

Published: 2012

Journal Articles

Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

Mathieu Kuentz, Marie Robin, Nathalie Dhedin, Yosr Hicheri, Regis Peffault de Latour, Pierre Rohrlich, Pierre Bordigoni, Bénédicte Bruno, Gérard Socié, Françoise Bernaudin

Blood (2011) 118 (16): 4491–4492.

https://doi.org/10.1182/blood-2011-07-367490

Published: 2011

Journal Articles

Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort

Blood (2011) 117 (4): 1130–1140.

https://doi.org/10.1182/blood-2010-06-293514

Published: 2011

Journal Articles

Myeloablative Bone Marrow Transplantation in Young Adults with Sickle Cell Disease: the French Experience

Mathieu Kuentz, Marie Robin, Nathalie Dhedin, Cécile Pautas, Regis Peffaut De La Tour, Pierre Rohrlich, Pierre Bordigoni, Gérard Socié, Catherine Cordonnier, Francoise Bernaudin

Blood (2010) 116 (21): 3516.

https://doi.org/10.1182/blood.V116.21.3516.3516

Published: 2010

Journal Articles

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Blood (2010) 116 (21): 3518.

https://doi.org/10.1182/blood.V116.21.3518.3518

Published: 2010

Journal Articles

Impact of Genetic Abnormalities After Allogeneic Stem Cell Transplantation in Multiple Myeloma: Report of the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

Blood (2009) 114 (22): 1187.

https://doi.org/10.1182/blood.V114.22.1187.1187

Published: 2009

Journal Articles

HLA-E up-Regulation on IFN-γ Activated AML Blasts Impaired CD94/ NKG2A-Dependent NK Cytolysis Following Haplo-Mismatched Haematopoietic Stem-Cell Transplantation

Stéphanie Nguyen, Vivien Beziat, Nathalie Dhedin, Mathieu Kuentz, MD, Madalina Uzunov, Jean-Paul Vernant, Patrice Debre, Vincent Vieillard

Blood (2008) 112 (11): 366.

https://doi.org/10.1182/blood.V112.11.366.366

Published: 2008

Journal Articles

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: French Society of Bone Marrow Graft Transplantation and Cellular Therapy Experience

Jacques-Olivier Bay, Aurelie Cabrespine-Faugeras, Reza Tabrizi, Pierre Bordigoni, Karin Bilger, Marc Renaud, Valerie Mialou, Marie Robin, Mathieu Kuentz, Patrice Chevallier, Nathalie Dhedin, Jean-Yves Cahn, Michel Attal, Didier Blaise, Mauricette Michallet

Blood (2008) 112 (11): 4293.

https://doi.org/10.1182/blood.V112.11.4293.4293

Published: 2008

Journal Articles

Does the Occurrence of Invasive Fungal Infection in Acute Leukemia Patients, Impact on the Chemotherapy Schedule and Event-Free Survival? a Case-Control Study

Caroline Even, MD, Sylvie Bastuji-Garin, MD, PhD, C.écile Pautas, MD, Yosr Hicheri, MD, Sebastien Maury, MD, MhD, Mathieu Kuentz, MD, Stephane Bretagne, MD, PhD, Catherine Cordonnier, MD

Blood (2008) 112 (11): 3980.

https://doi.org/10.1182/blood.V112.11.3980.3980

Published: 2008

Journal Articles

Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients

Michael Schwarzinger, Sylvain Baillot, Celine Beauchamp, Sebastien Maury, C. écile Pautas, MD, Anne Vekhoff, Hassan Farhat, Felipe Suarez, Francois Hemery, Mathieu Kuentz, MD, Catherine Cordonnier, MD

Blood (2008) 112 (11): 1314.

https://doi.org/10.1182/blood.V112.11.1314.1314

Published: 2008

Journal Articles

Antithymocyte Globulins (ATG) as Part of the Myeloablative Conditioning (MAC) Regimen Can Reduce the Risk of Severe Graft-Vs.-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT) from Matched-Unrelated Donors (MUD).

Mohamad Mohty, MD, PhD, Marie- Lorraine Balere, Gerard Socie, Noel-Jean Milpied, PhD, Norbert Ifrah, MD, Mathieu Kuentz, MD, Jean-Luc Harousseau, Jean-Paul Vernant, Mauricette Michallet, MD, Agnes Buzyn, Jean-Yves Cahn, Jean-Henri Bourhis, Didier Blaise, MD, Colette Raffoux, Helene Esperou, Ibrahim Yakoub-Agha, MD, PhD

Blood (2008) 112 (11): 1151.

https://doi.org/10.1182/blood.V112.11.1151.1151

Published: 2008

Journal Articles

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

Coralie Chaise, Sarah L. Buchan, Jason Rice, Jeanine Marquet, Hélène Rouard, Mathieu Kuentz, Gisella E. Vittes, Valérie Molinier-Frenkel, Jean-Pierre Farcet, Hans J. Stauss, Marie-Hélène Delfau-Larue, Freda K. Stevenson

Blood (2008) 112 (7): 2956–2964.

https://doi.org/10.1182/blood-2008-02-137695

Published: 2008

Journal Articles

Searching for factors to improve the antileukemic effect of donor lymphocyte infusion

Sébastien Maury, Catherine Cordonnier, Mathieu Kuentz, David Klatzmann, José L. Cohen

Blood (2008) 111 (10): 5256.

https://doi.org/10.1182/blood-2008-02-140491

Published: 2008

Journal Articles

Response: Late effects of myeloablative stem cell transplantation or late effects of sickle cell disease itself?

Françoise Bernaudin, Mathieu Kuentz, Gérard Socié

Blood (2008) 111 (3): 1744.

https://doi.org/10.1182/blood-2007-11-121475

Published: 2008

NARROW

Immune Reconstitution in 107 Children with Sickle Cell Anemia Transplanted with Bone Marrow or Cord Blood from a Matched-Sibling Donor after Myeloablative Conditioning Regimen Including 20mg/Kg ATG

Alternative Donor Hematopoietic Stem Cell Transplantation for Sickle Cell Disease in Europe

Risk Factors and Outcomes According to Age at Transplant with an HLA Identical Sibling for Sickle Cell Disease

Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation

Haploidentical Bone Marrow Transplant with Post-Transplant Cytoxan Plus Thiotepa Improves Donor Engraftment in Patients with Sickle Cell Anemia: Results of an International Multicenter Learning Collaborative

Sickle Cell Anemia and HSCT: Relation Between ATG, Chimerism, Gvhd and Outcome In Myeloablative Genoidentical Transplants For The SFGM-TC

Haplo-BMT: cure or back to sickle cell?

Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort

Myeloablative Bone Marrow Transplantation in Young Adults with Sickle Cell Disease: the French Experience

Related Myeloablative Stem Cell Transplantation (SCT) to Cure Sickle Cell Anemia (SCA): Update of French Results

Impact of Genetic Abnormalities After Allogeneic Stem Cell Transplantation in Multiple Myeloma: Report of the Societe Francaise De Greffe De Moelle Et De Therapie Cellulaire.

HLA-E up-Regulation on IFN-γ Activated AML Blasts Impaired CD94/ NKG2A-Dependent NK Cytolysis Following Haplo-Mismatched Haematopoietic Stem-Cell Transplantation

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: French Society of Bone Marrow Graft Transplantation and Cellular Therapy Experience

Does the Occurrence of Invasive Fungal Infection in Acute Leukemia Patients, Impact on the Chemotherapy Schedule and Event-Free Survival? a Case-Control Study

Cost-Effectiveness of Antifungal Strategies in High-Risk Neutropenic Patients

Antithymocyte Globulins (ATG) as Part of the Myeloablative Conditioning (MAC) Regimen Can Reduce the Risk of Severe Graft-Vs.-Host Disease (GVHD) after Allogeneic Stem Cell Transplantation (allo-SCT) from Matched-Unrelated Donors (MUD).

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

Searching for factors to improve the antileukemic effect of donor lymphocyte infusion

Response: Late effects of myeloablative stem cell transplantation or late effects of sickle cell disease itself?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only